🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12361+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12361 recruiting trials

NARecruitingNCT06083714

Effect of Scapular Stabilization Exercises in Individuals With Adolescent Idiopathic Scoliosis

🏥 Lokman Hekim University📍 1 site📅 Started Mar 2024View details ↗
Phase 4RecruitingNCT05514015

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

🏥 First Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06435000

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

🏥 Splice Bio📍 20 sites📅 Started Mar 2024View details ↗
NARecruitingNCT07136844

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

👨‍⚕️ Laurent Servais, MD, Centre Hospitalier Universitaire de Liege📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06340737

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

👨‍⚕️ Matthew Frank, MD, PhD, Stanford University📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06375941

Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars

👨‍⚕️ Elena Palassini, IRCCS Istituto nazionale Tumori - Milano📍 19 sites📅 Started Mar 2024View details ↗
Phase 3RecruitingNCT06291376

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

🏥 Alexion Pharmaceuticals, Inc.📍 267 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06220201

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 35 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06308978

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

🏥 Fate Therapeutics📍 17 sites📅 Started Mar 2024View details ↗
RecruitingNCT06364579

Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).

👨‍⚕️ Stefania Manfrida, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05828069

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

👨‍⚕️ Carl E Allen, Children's Oncology Group📍 115 sites📅 Started Mar 2024View details ↗
NARecruitingNCT05951101

Zenith LAA Occlusion System

👨‍⚕️ Felix Mahfoud, Internal Medicine and Cardiology, Saarland University Hospital📍 3 sites📅 Started Mar 2024View details ↗
NARecruitingNCT05655078

Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

👨‍⚕️ Crispin Hiley, University College, London📍 25 sites📅 Started Mar 2024View details ↗
RecruitingNCT06157268

The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.

👨‍⚕️ Nicol Voermans, MD PhD, Radboud University Medical Center📍 2 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06286709

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

🏥 University of Birmingham📍 5 sites📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT06083883

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

👨‍⚕️ John Livingston, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Mar 2024View details ↗
Phase 1, PHASE2RecruitingNCT06239272

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

👨‍⚕️ Jessica Gartrell, MD, St. Jude Children's Research Hospital📍 6 sites📅 Started Mar 2024View details ↗
RecruitingNCT06271018

TocILizumab in aorTitis in GCA (TILT)

🏥 Groupe français d'étude des Maladies Inflammatoires de loeil📍 1 site📅 Started Mar 2024View details ↗
NARecruitingNCT06224413

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

👨‍⚕️ Kiran Bhirangi, MD, bluebird bio, Inc.📍 3 sites📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT06613269

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Mar 2024View details ↗
← PreviousPage 313 of 619Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →